Since 2016, the Patient Safety Summit has provided a platform for exchange between representatives from politics, science and practice worldwide. It was launched by Germany and Great Britain. This year, representatives from 50 countries and international organizations such as the WHO, represented by Director General Dr. Tedros Adhanom Ghebreyesus, ICN and IAPO on March 2nd and 3rd
This year, from March 2nd to 3rd, representatives from 49 countries and international organizations such as the WHO, ICN and IAPO debated. In addition to digitization, the linking of reporting and learning systems, drug therapy safety and economic issues were on the agenda. The results were recorded in the Jeddah Declaration on Patient Safety issued by the participating countries.